Cargando…
Morbidity Analysis of the Notifiable Infectious Diseases in China, 2018
What is already known about this topic? Annual morbidity analysis reports that summarized trends and changing epidemiology for notifiable diseases were published in 2013 and 2015 (1,2). What is added by this report? In 2018, the morbidity of national notifiable diseases was 559.41 per 100,000 popula...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422198/ https://www.ncbi.nlm.nih.gov/pubmed/34594603 |
_version_ | 1783749241722634240 |
---|---|
author | Dong, Shuaibing Ren, Xiang Zhang, Cuihong Geng, Mengjie Zhu, Yuliang Shi, Lusha Zhang, Lijie Li, Zhongjie Wang, Liping |
author_facet | Dong, Shuaibing Ren, Xiang Zhang, Cuihong Geng, Mengjie Zhu, Yuliang Shi, Lusha Zhang, Lijie Li, Zhongjie Wang, Liping |
author_sort | Dong, Shuaibing |
collection | PubMed |
description | What is already known about this topic? Annual morbidity analysis reports that summarized trends and changing epidemiology for notifiable diseases were published in 2013 and 2015 (1,2). What is added by this report? In 2018, the morbidity of national notifiable diseases was 559.41 per 100,000 population, an increase of 12.88% compared with the average rate between 2015–2017. The five notifiable diseases with the highest reported morbidity were hand, foot, and mouth disease (HFMD), infectious diarrhea, hepatitis B, tuberculosis, and influenza. The five regions with the highest reported morbidity of infectious diseases were Zhejiang Province, Guangxi Autonomous Region, Guangdong Province, Beijing Municipality, and Xinjiang Autonomous Region. What are the implications for public health practice? Evidence on notifiable disease morbidity trends and changing epidemiology should help disease control and prevention agencies and medical institutions direct their response and prevention efforts. In addition, this report demonstrates the continued need for surveillance systems and high-quality data to identify focal points for disease control. |
format | Online Article Text |
id | pubmed-8422198 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-84221982021-09-29 Morbidity Analysis of the Notifiable Infectious Diseases in China, 2018 Dong, Shuaibing Ren, Xiang Zhang, Cuihong Geng, Mengjie Zhu, Yuliang Shi, Lusha Zhang, Lijie Li, Zhongjie Wang, Liping China CDC Wkly Vital Surveillances What is already known about this topic? Annual morbidity analysis reports that summarized trends and changing epidemiology for notifiable diseases were published in 2013 and 2015 (1,2). What is added by this report? In 2018, the morbidity of national notifiable diseases was 559.41 per 100,000 population, an increase of 12.88% compared with the average rate between 2015–2017. The five notifiable diseases with the highest reported morbidity were hand, foot, and mouth disease (HFMD), infectious diarrhea, hepatitis B, tuberculosis, and influenza. The five regions with the highest reported morbidity of infectious diseases were Zhejiang Province, Guangxi Autonomous Region, Guangdong Province, Beijing Municipality, and Xinjiang Autonomous Region. What are the implications for public health practice? Evidence on notifiable disease morbidity trends and changing epidemiology should help disease control and prevention agencies and medical institutions direct their response and prevention efforts. In addition, this report demonstrates the continued need for surveillance systems and high-quality data to identify focal points for disease control. Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2019-12 /pmc/articles/PMC8422198/ /pubmed/34594603 Text en Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2019 https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) |
spellingShingle | Vital Surveillances Dong, Shuaibing Ren, Xiang Zhang, Cuihong Geng, Mengjie Zhu, Yuliang Shi, Lusha Zhang, Lijie Li, Zhongjie Wang, Liping Morbidity Analysis of the Notifiable Infectious Diseases in China, 2018 |
title | Morbidity Analysis of the Notifiable Infectious Diseases in China, 2018 |
title_full | Morbidity Analysis of the Notifiable Infectious Diseases in China, 2018 |
title_fullStr | Morbidity Analysis of the Notifiable Infectious Diseases in China, 2018 |
title_full_unstemmed | Morbidity Analysis of the Notifiable Infectious Diseases in China, 2018 |
title_short | Morbidity Analysis of the Notifiable Infectious Diseases in China, 2018 |
title_sort | morbidity analysis of the notifiable infectious diseases in china, 2018 |
topic | Vital Surveillances |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422198/ https://www.ncbi.nlm.nih.gov/pubmed/34594603 |
work_keys_str_mv | AT dongshuaibing morbidityanalysisofthenotifiableinfectiousdiseasesinchina2018 AT renxiang morbidityanalysisofthenotifiableinfectiousdiseasesinchina2018 AT zhangcuihong morbidityanalysisofthenotifiableinfectiousdiseasesinchina2018 AT gengmengjie morbidityanalysisofthenotifiableinfectiousdiseasesinchina2018 AT zhuyuliang morbidityanalysisofthenotifiableinfectiousdiseasesinchina2018 AT shilusha morbidityanalysisofthenotifiableinfectiousdiseasesinchina2018 AT zhanglijie morbidityanalysisofthenotifiableinfectiousdiseasesinchina2018 AT lizhongjie morbidityanalysisofthenotifiableinfectiousdiseasesinchina2018 AT wangliping morbidityanalysisofthenotifiableinfectiousdiseasesinchina2018 |